新型内酯酮内酯类抗生素纳菲霉素纸片扩散法与MIC质控范围的确定
本研究按照CLSI M23文件二级研究方案,由九家实验室共同确定纳菲霉素对五种质控菌株的纸片扩散法和MIC质控范围。所有质控范围经CLSI抗菌药物敏感性试验分委员会2015年6月会议批准,并首次发表于2017年M100S文件,推荐用于临床试验及后续患者分离株检测。
要点
- 纳菲霉素对金黄色葡萄球菌ATCC 25923纸片扩散质控范围为25-31 mm。
- 纳菲霉素对肺炎链球菌ATCC 49619纸片扩散质控范围为25-31 mm,MIC质控范围为0.008-0.03 μg/ml。
- 纳菲霉素对流感嗜血杆菌ATCC 49247纸片扩散质控范围为16-20 mm,MIC质控范围为2-8 μg/ml。
核心结论
- 纳菲霉素对五种质控菌株的纸片扩散法和MIC质控范围已按CLSI M23二级研究方案确定并经CLSI批准。
- 所建立的质控范围应适用于纳菲霉素的体外活性测定,包括2期和3期人体临床试验以及后续患者分离株和4期监测研究。
研究设计与样本
- 九家实验室参与的CLSI M23文件定义的二级研究,用于确定纳菲霉素的纸片扩散法和MIC质控范围。
- 测试了5株与纳菲霉素抗菌谱一致的质控菌株:金黄色葡萄球菌ATCC 25923(仅纸片法)、金黄色葡萄球菌ATCC 29213(仅肉汤法)、粪肠球菌ATCC 29212(仅肉汤法)、肺炎链球菌ATCC 49619(纸片法和肉汤法)、流感嗜血杆菌ATCC 49247(纸片法和肉汤法)。
主要发现
- 纸片扩散法质控范围:金黄色葡萄球菌ATCC 25923为25-31 mm,肺炎链球菌ATCC 49619为25-31 mm,流感嗜血杆菌ATCC 49247为16-20 mm。
- MIC质控范围:金黄色葡萄球菌ATCC 29213为0.06-0.25 μg/ml,粪肠球菌ATCC 29212为0.016-0.12 μg/ml,肺炎链球菌ATCC 49619为0.008-0.03 μg/ml,流感嗜血杆菌ATCC 49247为2-8 μg/ml。
关键数值与推荐
- 纸片扩散法质控范围:金黄色葡萄球菌ATCC 25923 25-31 mm;肺炎链球菌ATCC 49619 25-31 mm;流感嗜血杆菌ATCC 49247 16-20 mm。
- MIC质控范围:金黄色葡萄球菌ATCC 29213 0.06-0.25 μg/ml;粪肠球菌ATCC 29212 0.016-0.12 μg/ml;肺炎链球菌ATCC 49619 0.008-0.03 μg/ml;流感嗜血杆菌ATCC 49247 2-8 μg/ml。
- 所有质控范围经CLSI抗菌药物敏感性试验分委员会2015年6月会议批准,并首次报告于2017年M100S文件。
临床怎么用
- 临床微生物实验室应采用本研究建立的质控范围对纳菲霉素进行体外药敏试验的质控。
- 这些质控范围可用于检测患者分离株以及4期监测研究中的分离株。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Disk diffusion and MIC quality control (QC) ranges were determined for nafithromycin, a new lactone-ketolide, following the completion of a nine-laboratory, Clinical and Laboratory Standards Institute (CLSI) document M23-defined tier 2 study. Five QC strains consistent with the spectrum of activity of nafithromycin were tested: Staphylococcus aureus ATCC 25923 (disk only), S. aureus ATCC 29213 (broth only), Enterococcus faecalis ATCC 29212 (broth only), Streptococcus pneumoniae ATCC 49619 (disk and broth), and Haemophilus influenzae ATCC 49247 (disk and broth). Nafithromycin disk diffusion QC ranges were determined to be 25 to 31 mm for S. aureus ATCC 25923, 25 to 31 mm for S. pneumoniae ATCC 49619, and 16 to 20 mm for H. influenzae ATCC 49247. Nafithromycin MIC QC ranges were determined to be 0.06 to 0.25 μg/ml for S. aureus ATCC 29213, 0.016 to 0.12 μg/ml for E. faecalis ATCC 29212, 0.008 to 0.03 μg/ml for S. pneumoniae ATCC 49619, and 2 to 8 μg/ml for H. influenzae ATCC 49247. All disk diffusion and MIC QC ranges established in this study were approved by the CLSI Subcommittee on Antimicrobial Susceptibility Testing at their June 2015 meeting and were initially reported in the 2017 M100S document. The QC ranges established in this study should be used for determining the in vitro activity of nafithromycin in phase 2 and phase 3 human clinical trials and subsequently for testing patient isolates and isolates in phase 4 surveillance studies.
引用
- Hackel MA, Karlowsky JA, Dressel D, et al. Determination of Disk Diffusion and MIC Quality Control Ranges for Nafithromycin (WCK 4873), a New Lactone-Ketolide. J Clin Microbiol. 2017. PMID: 28747372. doi:10.1128/JCM.00972-17
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。